{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:02:47Z","timestamp":1787504567540,"version":"build-2736575974"},"reference-count":47,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>PF4-dependent disorders encompass a heterogeneous group of immune-mediated thrombotic syndromes, including heparin-induced thrombocytopenia (HIT), its autoimmune variants such as spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia (VITT). The recent identification of VITT and VITT-like entities has significantly expanded the diagnostic spectrum, complicating the retrospective interpretation of cases that occurred before their formal recognition. We report the case of a young patient who initially presented with a clinical and biological presentation suggestive of atypical HIT, at a time when neither spontaneous HIT nor VITT were defined. The patient was re-evaluated during the COVID-19 vaccination campaign, prompting a reassessment of the initial diagnosis in light of current knowledge on PF4-related disorders, which continue to increase in both diversity and complexity. A critical review of clinical and laboratory findings now favors a diagnosis of VITT-like syndrome over spontaneous HIT, although confirmatory testing is no longer feasible given the time elapsed since the acute phase. This case highlights the importance of revisiting historical cases using updated diagnostic criteria to improve the identification and management of these emerging and underrecognized syndromes.<\/jats:p>","DOI":"10.3390\/life15111767","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T16:49:51Z","timestamp":1763484591000},"page":"1767","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Reassessment of a Historical Case of Atypical Heparin-Induced Thrombocytopenia: Between Spontaneous Heparin-Induced Thrombocytopenia and a Vaccine-Induced Immune Thrombotic Thrombocytopenia-Like Syndrome"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4150-1631","authenticated-orcid":false,"given":"Jordan","family":"Wimmer","sequence":"first","affiliation":[{"name":"Laboratoire D\u2019h\u00e9matologie Biologique, Unit\u00e9 H\u00e9mostase, H\u00f4pitaux Universitaires de Strasbourg, 67200 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne","family":"Kirscher","sequence":"additional","affiliation":[{"name":"Centre de Ressource et Comp\u00e9tence des Maladies H\u00e9morragiques Constitutionnelles, H\u00f4pitaux Universitaires de Strasbourg, 67200 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0385-8651","authenticated-orcid":false,"given":"Manon","family":"Dolt","sequence":"additional","affiliation":[{"name":"Laboratoire D\u2019h\u00e9matologie Biologique, Unit\u00e9 H\u00e9mostase, H\u00f4pitaux Universitaires de Strasbourg, 67200 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1040-0086","authenticated-orcid":false,"given":"Agathe","family":"Herb","sequence":"additional","affiliation":[{"name":"Laboratoire D\u2019h\u00e9matologie Biologique, Unit\u00e9 H\u00e9mostase, H\u00f4pitaux Universitaires de Strasbourg, 67200 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Pierre","sequence":"additional","affiliation":[{"name":"Centre de Ressource et Comp\u00e9tence des Maladies H\u00e9morragiques Constitutionnelles, H\u00f4pitaux Universitaires de Strasbourg, 67200 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9lia","family":"Grunebaum","sequence":"additional","affiliation":[{"name":"Laboratoire D\u2019h\u00e9matologie Biologique, Unit\u00e9 H\u00e9mostase, H\u00f4pitaux Universitaires de Strasbourg, 67200 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Feugeas","sequence":"additional","affiliation":[{"name":"Centre de Ressource et Comp\u00e9tence des Maladies H\u00e9morragiques Constitutionnelles, H\u00f4pitaux Universitaires de Strasbourg, 67200 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2702-6246","authenticated-orcid":false,"given":"Laurent","family":"Sattler","sequence":"additional","affiliation":[{"name":"Laboratoire D\u2019h\u00e9matologie Biologique, Unit\u00e9 H\u00e9mostase, H\u00f4pitaux Universitaires de Strasbourg, 67200 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Desprez","sequence":"additional","affiliation":[{"name":"Centre de Ressource et Comp\u00e9tence des Maladies H\u00e9morragiques Constitutionnelles, H\u00f4pitaux Universitaires de Strasbourg, 67200 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Warkentin, T.E. (2025). Classification of Platelet-Activating Anti-Platelet Factor 4 Disorders. Int. J. Lab. Hematol.","DOI":"10.1111\/ijlh.14486"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJMc2307721","article-title":"Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies","volume":"389","author":"Warkentin","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1007\/s00415-024-12373-6","article-title":"An anti-PF4 antibody-related disorder with cerebral venous sinus thrombosis and thrombocytopenia initially presenting as intracranial hemorrhage","volume":"271","author":"Wittstock","year":"2024","journal-title":"J. Neurol."},{"key":"ref_7","first-page":"725","article-title":"Anticorps anti-PF4 et thrombop\u00e9nie chez un enfant avec thrombophl\u00e9bite c\u00e9r\u00e9brale","volume":"68","author":"Desprez","year":"2010","journal-title":"Ann. Biol. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"102729","DOI":"10.1016\/j.rpth.2025.102729","article-title":"Anti-Platelet factor 4 immunothrombosis\u2014Not just heparin and vaccine triggers","volume":"9","author":"Wang","year":"2025","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-135-7-200110020-00009","article-title":"Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-136-3-200202050-00009","article-title":"Delayed-Onset Heparin-Induced Thrombocytopenia","volume":"136","author":"Rice","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.amjmed.2008.03.012","article-title":"A Spontaneous Prothrombotic Disorder Resembling Heparin-induced Thrombocytopenia","volume":"121","author":"Warkentin","year":"2008","journal-title":"Am. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2324709619832324","DOI":"10.1177\/2324709619832324","article-title":"Refractory Heparin-Induced Thrombocytopenia with Cerebral Venous Sinus Thrombosis Treated with IVIg, Steroids, and a Combination of Anticoagulants: A Case Report","volume":"7","author":"Gonzales","year":"2019","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1177\/00031348231161690","article-title":"A Case of Argatroban Refractory Heparin Induced Thrombocytopenia and Thrombosis","volume":"89","author":"Seiler","year":"2023","journal-title":"Am. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1182\/blood-2017-06-788679","article-title":"Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma","volume":"130","author":"Mian","year":"2017","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1160\/TH07-06-0423","article-title":"Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: A consequence of heparin \u201cflushes\u201d","volume":"98","author":"Refaai","year":"2007","journal-title":"Thromb. Haemost."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1056\/NEJMc070346","article-title":"Heparin-Induced Thrombocytopenia Associated with Fondaparinux","volume":"356","author":"Te","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1160\/th14-08-0711","article-title":"HIT complicating fondaparinux prophylaxis: Fondaparinux-dependent platelet activation as a marker for fondaparinux- induced HIT","volume":"112","author":"Warkentin","year":"2014","journal-title":"Thromb. Haemost."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2021.05.018","article-title":"Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia","volume":"204","author":"Warkentin","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1160\/TH11-12-0825","article-title":"Rapid onset heparin-induced thrombocytopenia (HIT) without history of heparin exposure: A new case of so-called \u2018spontaneous\u2019 HIT","volume":"107","author":"Perrin","year":"2012","journal-title":"Thromb. Haemost."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1538-7836.2008.03040.x","article-title":"Fatal heparin-induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: Another example of \u2018spontaneous\u2019 HIT?","volume":"6","author":"Jay","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"ref_22","first-page":"4918623","article-title":"Spontaneous Heparin-Induced Thrombocytopenia and Venous Thromboembolism following Total Knee Arthroplasty","volume":"2017","author":"Baker","year":"2017","journal-title":"Case Rep. Hematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ajh.2830450312","article-title":"Pentosan polysulfate-induced thrombocytopenia and thrombosis","volume":"45","author":"Tardy","year":"1994","journal-title":"Am. J. Hematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2141.1992.tb08216.x","article-title":"Heparin-associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: Evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan","volume":"81","author":"Greinacher","year":"1992","journal-title":"Br. J. Haematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hematology.2023000503","article-title":"Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond","volume":"2023","author":"Greinacher","year":"2023","journal-title":"Hematology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood-2012-06-434985","article-title":"Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4\/heparin-like epitopes","volume":"120","author":"Krauel","year":"2012","journal-title":"Blood"},{"key":"ref_27","first-page":"1105","article-title":"Bacteria and HIT: A close connection?","volume":"117","author":"Gruel","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.thromres.2013.06.013","article-title":"Antiplatelet factor 4\/heparin antibodies in patients with gram negative bacteremia","volume":"132","author":"Pongas","year":"2013","journal-title":"Thromb. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.2023021307","article-title":"Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT","volume":"143","author":"Wang","year":"2024","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/ATVBAHA.122.317162","article-title":"Thromboinflammation: From Atherosclerosis to COVID-19","volume":"42","author":"Wagner","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/bloodadvances.2024014165","article-title":"Endothelial cell activation enhances thromboinflammation in vaccine-induced immune thrombotic thrombocytopenia","volume":"9","author":"Dupuy","year":"2025","journal-title":"Blood Adv."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/blood.2021014588","article-title":"Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT","volume":"140","author":"Kanack","year":"2022","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/bjh.19885","article-title":"Genetic predisposition to vaccine-induced immune thrombotic thrombocytopenia","volume":"206","author":"Arnold","year":"2025","journal-title":"Br. J. Haematol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood.2023022136","article-title":"Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure","volume":"142","author":"Esteban","year":"2023","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMc2402592","article-title":"Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders","volume":"390","author":"Wang","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jth.15604","article-title":"Thrombosis and thrombocytopenia after HPV vaccination","volume":"20","author":"Johansen","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lin, T.C., Fu, P.A., Hsu, Y.T., and Chen, T.Y. (2023). Vaccine-Induced Immune Thrombotic Thrombocytopenia following BNT162b2 mRNA COVID-19 Booster: A Case Report. Vaccines, 11.","DOI":"10.3390\/vaccines11061115"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"102641","DOI":"10.1016\/j.rpth.2024.102641","article-title":"Mini-clusters of postadenovirus VITT","volume":"9","author":"Lambert","year":"2025","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"102589","DOI":"10.1016\/j.rpth.2024.102589","article-title":"A cluster of pediatric VITT-like cases with thrombosis and thrombocytopenia following respiratory infections-Case series","volume":"8","author":"Dimopoulou","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/bjh.20092","article-title":"Anti-PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT-like and VITT-like characteristics","volume":"206","author":"Nicolson","year":"2025","journal-title":"Br. J. Haematol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0042-1758818","article-title":"Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review","volume":"49","author":"Warkentin","year":"2023","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.jtha.2023.04.034","article-title":"Investigation of anti-PF4 versus anti-PF4\/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: Classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT","volume":"21","author":"Warkentin","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/bjh.14955","article-title":"Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies","volume":"179","author":"Vayne","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1056\/NEJMc2106383","article-title":"PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia","volume":"385","author":"Vayne","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1111\/jth.15862","article-title":"Quantitative interpretation of PF4\/heparin-EIA optical densities in predicting platelet-activating VITT antibodies","volume":"20","author":"Thiele","year":"2022","journal-title":"J. Thromb. Haemost."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/11\/1767\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T17:00:47Z","timestamp":1763485247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/11\/1767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["life15111767"],"URL":"https:\/\/doi.org\/10.3390\/life15111767","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]}}}